Advanced search
1 file | 393.74 KB Add to list

Impact of conjugate 7-valent vaccination in Belgium: addressing methodological challenges

(2011) VACCINE. 29(16). p.2856-2864
Author
Organization
Keywords
NONVACCINE SEROTYPES, ANTIBIOTIC USE, ACUTE OTITIS-MEDIA, PNEUMONIAE SEROTYPE 19A, INVASIVE PNEUMOCOCCAL DISEASE, Pneumococcal conjugate vaccine, Epidemiology, Surveillance, ERA, REPLACEMENT, UNITED-STATES, CHILDREN, RESISTANCE

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 393.74 KB

Citation

Please use this url to cite or link to this publication:

MLA
Hanquet, Germaine, Tinne Lernout, Anne Vergison, et al. “Impact of Conjugate 7-valent Vaccination in Belgium: Addressing Methodological Challenges.” VACCINE 29.16 (2011): 2856–2864. Print.
APA
Hanquet, G., Lernout, T., Vergison, A., Verhaegen, J., Kissling, E., Tuerlinckx, D., Malfroot, A., et al. (2011). Impact of conjugate 7-valent vaccination in Belgium: addressing methodological challenges. VACCINE, 29(16), 2856–2864.
Chicago author-date
Hanquet, Germaine, Tinne Lernout, Anne Vergison, Jan Verhaegen, Esther Kissling, David Tuerlinckx, Anne Malfroot, Beatrice Swennen, and Martine Sabbe. 2011. “Impact of Conjugate 7-valent Vaccination in Belgium: Addressing Methodological Challenges.” Vaccine 29 (16): 2856–2864.
Chicago author-date (all authors)
Hanquet, Germaine, Tinne Lernout, Anne Vergison, Jan Verhaegen, Esther Kissling, David Tuerlinckx, Anne Malfroot, Beatrice Swennen, and Martine Sabbe. 2011. “Impact of Conjugate 7-valent Vaccination in Belgium: Addressing Methodological Challenges.” Vaccine 29 (16): 2856–2864.
Vancouver
1.
Hanquet G, Lernout T, Vergison A, Verhaegen J, Kissling E, Tuerlinckx D, et al. Impact of conjugate 7-valent vaccination in Belgium: addressing methodological challenges. VACCINE. 2011;29(16):2856–64.
IEEE
[1]
G. Hanquet et al., “Impact of conjugate 7-valent vaccination in Belgium: addressing methodological challenges,” VACCINE, vol. 29, no. 16, pp. 2856–2864, 2011.
@article{4231434,
  author       = {{Hanquet, Germaine and Lernout, Tinne and Vergison, Anne and Verhaegen, Jan and Kissling, Esther and Tuerlinckx, David and Malfroot, Anne and Swennen, Beatrice and Sabbe, Martine}},
  issn         = {{0264-410X}},
  journal      = {{VACCINE}},
  keywords     = {{NONVACCINE SEROTYPES,ANTIBIOTIC USE,ACUTE OTITIS-MEDIA,PNEUMONIAE SEROTYPE 19A,INVASIVE PNEUMOCOCCAL DISEASE,Pneumococcal conjugate vaccine,Epidemiology,Surveillance,ERA,REPLACEMENT,UNITED-STATES,CHILDREN,RESISTANCE}},
  language     = {{eng}},
  number       = {{16}},
  pages        = {{2856--2864}},
  title        = {{Impact of conjugate 7-valent vaccination in Belgium: addressing methodological challenges}},
  url          = {{http://dx.doi.org/10.1016/j.vaccine.2011.02.016}},
  volume       = {{29}},
  year         = {{2011}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: